Transaction Update Announcement

RNS Number : 3093G
JPMorgan Global Growth & Income PLC
29 March 2022
 

 

29 March 2022

 

JPMorgan Global Growth & Income plc

 

Legal Entity Identifier: 5493007C3I0O5PJKR078

 

Proposed combination with The Scottish Investment Trust PLC

 

Transaction Update

 

The Board of JPMorgan Global Growth & Income plc ("JGGI" or the "Company") announces that it has been advised by The Scottish Investment Trust PLC ("SCIN") that SCIN has completed the buy-in of the benefits under its pension scheme with an insurer, as outlined in the announcement by SCIN on 20 October 2022.

 

The debt workstreams are, however, taking longer than anticipated and, as such, the Transaction is expected to conclude around the end of Q2 2022, rather than the end of Q1 2022 as previously indicated.

 

The Company's prospectus and circular in connection with the Scheme is expected to be published following the meeting of the SCIN debt holders and a further update will be provided in due course.

 

Terms used in this announcement shall, unless the context otherwise requires, bear the meanings given to them in the announcement by the Company on 20 October 2021.

 

 

For further information please contact:

 

JPMorgan Global Growth & Income plc

Tristan Hillgarth

 

Contact via Lansons

JPMorgan Funds Limited

Simon Crinage

Fin Bodman

 

 

+44 (0) 20 7742 3445

+44 (0) 20 7742 8651 

JPMorgan Funds Limited (Company Secretary)  

Divya Amin

 

+44 (0) 20 7742 4000

Winterflood Securities Limited

Neil Langford

Chris Mills

 

+44 (0) 20 3100 0000

Lansons

Henrietta Guthrie

+44 (0) 7788 454776

 

 

Important Information

 

This announcement contains information that is inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. The person responsible for arranging for the release of this announcement on behalf of JPMorgan Global Growth & Income plc is Divya Amin of JPMorgan Funds Limited.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDXCDDDGDI
UK 100

Latest directors dealings